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Abstract.  EGF receptor internalization,  recycling, and 
downregulation were evaluated in liver parenchyma as 
a  function of increasing doses of injected EGE  The 
effect of ligand occupancy in vivo on the kinetics and 
extent of internalization  was studied with changes in 
the receptor content of isolated plasmalemma and en- 
dosome fractions evaluated by direct binding,  Scatch- 
ard analysis, and Western blotting.  For all doses of in- 
jected EGF, receptor was lost from the plasmalemma 
and accumulated in endosomes in a time- and dose- 
dependent fashion.  However, at doses of injected EGF 
equivalent to <50%  surface receptor occupancy (i.e., 
<1  #g/100 g body weight), receptor levels returned by 
120 min to initial  values. This return  was resistant to 
cycloheximide and therefore did not represent newly 
synthesized receptor.  Neither was the return due to 
replenishment by an intracellular pool of low-affinity 
receptors as such a pool could not be detected by 
Scatchard analysis or Western blotting.  Therefore, 
receptor return was due to the recycling of previously 
internalized  receptor. 
At doses of injected EGF >50%  receptor occupancy, 
net receptor loss-i.e.,  downregulation-was observed 
by evaluating the receptor content of total particulate 
fractions of liver homogenates.  At the higher saturat- 
ing doses of injected EGF (5 and  10 #g/100 g body 
weight), the majority of surface receptor content was 
lost by 15 min and remained low for at least an addi- 
tional  105 min.  As the kinetics of ligand clearance 
from the circulation and liver parenchyma were simi- 
lar for all doses of EGF injected, then the ligand- 
mediated regulation of surface receptor content and 
downregulation were not a  result of a prolonged tem- 
poral interaction of ligand with receptor.  Rather,  the 
phenomena must be a consequence of the absolute 
concentrations of EGF interacting  with receptor at the 
cell surface and/or in endosomes. 
S 
HORTLY after binding  to target cells, EGF is internal- 
ized along with its receptor into components of the en- 
dosomal apparatus  (10, 11,  14,  15,  19, 31, 34, 36). It 
is here that ligand and receptor are thought to be targeted for 
transport  and  destruction  within  lysosomes,  leading  ulti- 
mately to clearance of the ligand  and downregulation  (net 
loss) of receptor (9,  16, 23, 27, 35). 
Liver parenchyma of male rats is enriched in EGF recep- 
tors (2,  14,  15,  19). Little is known of the relationship  be- 
tween surface recptor occupancy and the phenomenon of 
downregulation  in an in vivo context.  As well, the contribu- 
tion of receptor recycling to ligand and receptor uptake is un- 
clear (8, 14, 15, 22, 23, 27, 29). We have studied directly the 
in vivo interaction  of EGF with its receptor by assessing the 
dose response of receptor content in plasmalemma (PM), ~ 
Golgi apparatus  and endosome (GE), and total particulate 
(TP) fractions  isolated  from liver homogenates.  We show 
that downregulation  occurred only when >50% of surface 
receptors were occupied. At lower levels of surface receptor 
1. Abbreviations used in this paper: GE, Golgi apparatus and endosome; 
PM, plasmalemma; TP,  total particulate. 
occupancy, receptor accumulated temporarily in endosomes 
but returned to the cell surface as a regulated recycling event. 
Materials and Methods 
Materials 
EGF was purchased from Collaborative Research (Waltham, MA). Carrier- 
free Nal25I  was purchased from DuPont Canada Inc.  (Mississauga, On- 
tario,  Canada).  Reagents  for  SDS-PAGE  were  obtained  from  Bio-Rad 
Laboratories (Mississauga, Ontario, Canada). All other reagents and chem- 
icals were of the highest purity available and were purchased as described 
previously (19). 
Animals, Subcellular Fractionation, and 
Protein Determination 
Male Sprague-Dawley rats (120 +  5 g) were supplied hy Charles River (St. 
Constant, Quebec, Canada). Rats were fasted for 16 h before use. PM was 
isolated by the method of Hubbard et al. (17) and modified as described pre- 
viously (19). The GE fraction was also isolated as described previously (3) 
and used directly off the gradient without pelleting. GE fractions were re- 
covered at a  buoyant density of 1.09 g/cm  3.  The fraction is a  combined 
Golgi apparatus-endosom¢ fraction free of PM contamination (19) and is 
designated the GE fraction for purposes of the work described herein. TP 
fractions were obtained by centrifugation of homogenates at 200,000 gay for 
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determined by the method of Bradford (6). 
Ligand Iodination, Binding Assay, Scatchard Analysis, 
and Immunobiotting 
EGF was iodinated using the chloramine T procedure as described previ- 
ously  (26).  The specific activity of the  125I-EGF  was  180  +  3.2  (SD) 
/~Ci/t~g (n =  41). Direct binding studies were also carried out as described 
previously  (25)  with 25  mM Tris,  pH 7.4,  10 mM  MgCl2,  0.1%  BSA, 
1,000 kailikrein inhibitor units/ml aprotinin, 40-50/zg/tube of PM or GE 
cell fraction protein, and 75,000 dpm 125I-EGF in a final volume of 0.5 ml. 
Nonspecific binding was assessed by carrying out the incubations with ex- 
cess unlabeled EGF (25/~g/ml). The binding assay for TP fractions (1 mg/ 
tube cell fraction protein) was carried out in the presence or absence of 
0.05% N-octyl-/3-D-glucopyranoside (octylglucoside) at 4°C for 14 h with 
constant shaking and terminated by precipitation with polyethylene glycol 
and T-globulin and filtration onto Whatman filters as described (12) or cen- 
trifugation at 2,000 g for 30 min at 4°C. Other detergents that were screened 
-  i.e., Brij-35 (14, 15), Triton X-100, 3-([3-cholamidopropyl]dimethylam- 
moniol)-l-propane-snlfonate, and Tween 20 -  were considered unsuitable 
as these detergents at concentrations of 0.1-2%  inhibited specific binding 
by 20-45 % in TP fractions isolated from control (uninjected) rats. GE and 
TP fractions were also disrupted by freezing the fractions (-20°C)  and 
thawing three times. Correction for endogenous EGF hound in vivo to the 
PM or GE fractions was by the method of Desbuquois et al. (13) in which 
endogenous EGF was removed with 0.2 N  HCI containing 2% BSA and 
separated from membranes by recentrifugation and the supernatant was neu- 
tralized with 1 M Tris. The concentration of EGF in the neutralized super- 
natants was determined by radioreceptor assay and corrected values of EGF 
binding to membranes determined from the EGF content (Table I). The cor- 
rection factors were taken as the ratio of ~25I-EGF hound to freshly pre-  c 
pared PM fractions in the absence of added EGF vs. 125I-EGF hound in the 
presence of that EGF determined for the respective neutralized supernatants  o 
(see above),  o. 
The PM fraction revealed an average of 25.7  +  3.6% (n =  16) specific 
binding/50 ttg cell fraction protein, while GE fractions isolated from control  ~3 
rats showed an average of 6.9 +  1.7% (n  =  16) specific binding/50/~g cell  '~ 
fraction protein.  Scatcbard analyses were carried out on EGF  inhibition  o 
dose-response data after correction for the presence of endogenous EGF 
according to the two-site model as described previously (28). 
A  peptide corresponding to residues  1,164-1,176  of the EGF receptor 
(i.e., KGSTRENREYLRV) was synthesized by Dr. N. Ling (The Salk Insti- 
tute, San Diego, CA). The peptides were coupled to keyhole limpet hemo- 
cyanin, and polyclonal antibodies were raised after injection into rabbits. 
Immunoblotting was carried out on 50/~g protein of PM or GE fractions  Q- 
isolated at 0, 0.5, 5, and 15 min after the injection of 10/tg/100 g body weight  x3 
EGE The nitrocellulose paper containing the transferred protein was blocked 
with 5 % BSA in a buffer consisting of 0.3 M NaCI, 0.5 % Tween 20, 10 mM  O 
Tris-HCI, pH 7.4, for 30 rain at room temperature and then blocked with 
5 %  rat serum in the same buffer, The blocked nitrocellulose paper was  -~ 
treated with alkaline phosphatase at 3"/°C for 1 h and then incubated with  E 
the site-specific antibody (antiserum at 1:500 dilution) for 12 h at 4°C fol- 
lowed by =25I-goat anti-rabbit IgG antibody for 1 h at room temperature. 
Quantitation of EGF receptor content was by densitometry of x-ray films 
exposed to the nitrocellulose paper for 18 h at -70°C.  A linear response  ,~1 
in signal was observed over a range of 5-100/zg of PM or GE protein sub- 
jected to immunoblotting by this protocol.  N 
Electron Microscopy of  PM and GE Fractions 
For electron microscopy, subcellular fractions (50 #g cell fraction protein) 
were harvested straight from the density gradients and fixed immediately 
(see below) or incubated in 0.5 ml 25 mM Tris,  10 mM MgCl2, pH 7.4, 
in the presence of 0.1%  BSA at 4°C for 14 h with constant shaking as for 
the EGF binding assay described above (25).  Membranes were fixed in 
2.5% glutarnldehyde in 100 mM sodium cacodylate, pH 7.4, at 4°C. Sam- 
ples containing 30/~g cell fraction protein were filtered under N2 onto ni- 
trocellnlose filters (Millipore Continental Water Systems,  Bedford,  MA) 
using a filtration apparatus as described previously (1). Filters were post- 
fixed in 2% OsO4 in 100 mM cacodylate buffer, pH 7.4, and stained en 
bloc with  1% tannic acid (32) and 8% uranyl acetate in 100 mM maleic 
buffer, pH 5  (18), and processed for routine electron microscopy. 
At 60 rain after the intraperitoneal injection of cycloheximide (0.2 mg/100 
g body weight) [3H]L-leucine (2.5/~Ci/120 g body weight, 5 Ci/mmol sp 
act) was injected into the portal vein of rats injected with either cyclohexi- 
mide or PBS. "~A precipitation of liver homogenates prepared from rats 
killed at various times (1-8 h) after the injection of [3H]leucine showed 
>95 % inhibition of incorporation compared with liver homogenates from 
animals not injected with cycloheximide. For the experiments described in 
Results, a cycloheximide dose of 0.2 rag/100 g body weight was injected 120 
rain before the injection of EGE 
Inhibition of  Protein Synthesis by Cycloheximide 
The efficacy of cycloheximide inhibition of protein synthesis was evaluated. 
Clearance and Hepatic Uptake of '2JI-EGF 
t25I-EGF (0.1,  1, and 10 #g/100 g body weight) was injected into the hepatic 
portal vein of anesthetized fasted rats. At various times after 125I-EGF in- 
jection,  plasma was collected  from the aorta and centrifuged at 4°C  at 
1,500 g for 15 rain. Livers were quickly placed in ice-cold 0.25 M sucrose 
containing 4 mM immidazole, pH 7.5, to yield a 20% homogenate. Plasma 
samples and liver homogenates were precipitated with ice-cold 10% "ICA 
for 30 rain, and TCA-precipitable radioactivity was determined. 
Results 
Dose Response and Kinetics of Translocation of 
Binding Sites from the Cell Surface to Endosomes 
The kinetics  and dose response  of receptor internalization 
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Figure 1. Specific binding of 10  -I° M  ~2SI-EGF to PM and GE frac- 
tions  isolated  at  various  times  after  the  injection  of  0-10  ~,g 
EGF/100 g body weight as described in Materials and Methods. Di- 
rect binding with 10  -m M  ~25I-EGF was carried out on freshly pre- 
pared fractions and corrected for the presence of endogenous EGF 
as described in Materials and Methods and Tables I and II and ex- 
pressed as femtomoles of EGF specifically bound per milligram of 
cell  fraction protein. 
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EGF content at various times (min) after EGF injection 
Subcellular  Dose of 
fraction  EGF injected  0.5  I  2.5  5  15  30  60  120 
/,g/lO0 g body weight  pmol/mg cell fraction protein 
PM  0.1  0.51  0.51  0.51  0.48  0.46  0.51  0.15  0.15 
1  1.75  1.52  1.47  1.34  1.15  1.15  0.49  0.28 
10  5.30  4.64  4.64  4.30  4.14  2.67  0.99  0.71 
GE  0.1  0.50  0.60  0.81  1.09  1.16  1.13  0.60  0.50 
1  1.59  1.67  3.76  4.82  5.84  4.13  2.98  0.41 
10  2.30  4.92  20.15  29.77  23.39  16.00  7.09  4.01 
TP  0.1  0.15  0.17  0.13  0.07  0.08  0.03  0.08  0.08 
1  0.31  0.30  0.30  0.30  0.30  0.22  0.17  0.10 
10  0.77  0.77  1.00  1.25  1.66  1.17  1.10  0.34 
Subeellular fractions were prepared at the indicated times after the injection of 0.1,  1, and 10 t~g of EGF/100 g body weight, and EGF content was determined 
by radioreceptor assay as described in Materials and Methods. Data are averages from two or more separate experiments. 
and reappearance on the cell surface were evaluated for the 
binding domain of the EGF receptor. As before (19), subcel- 
lular fractions corresponding to the hepatic PM and a com- 
bined GE fraction were isolated from liver homogenates at 
various times after the portal  vein injection of EGE  No 
difference was observed whether direct binding studies were 
carried out on freshly prepared fractions or after freezing 
and thawing of the fractions three times. After 14 h of incu- 
bation in the hypotonic buffer used for the binding assays, 
electron microscopy revealed that GE fractions were dis- 
rupted, thereby accounting for the lack of latency in binding 
to this fraction (not shown). Direct binding studies on the 
fractions showed the temporal loss of binding sites from PM 
that coincided with entry into GE fractions (Fig. 1). No lag 
(i.e., <30 s) was observed in the accumulation of receptor 
into the GE fraction. The maximal extent of receptor loss 
from the PM occurred by 15 rain and appeared dose depen- 
dent as did the extent of accumulation of receptor into the 
GE fraction at peak times of internalization, which were also 
at 15 min. 
Unexpectedly, the receptor content of PM fractions after 
the injection of 0.1, 0.5,  and 1 ttg of EGF returned to near 
initial values by 30 min after the injection of the 0.1- and 0.5- 
~g doses and by 120 min after the 1-#g dose. For the 5- and 
10-~.g doses, the receptor content of the PM fractions re- 
mained low from 15 to 120 min after EGF injection. 
To derive the data of Fig. 1, direct binding was corrected 
for the presence of endogenous ligand in the fractions as a 
consequence of the doses of EGF injected. EGF content in 
the cell fractions was evaluated by radioreceptor assay (Table 
I) and as expected was dose and time dependent. GE fractions 
accumulated considerable quantities of EGF compared with 
PM fractions. Subsequent correction factors (Table 1I) were 
calculated as originally described by Desbuquois et al. (13). 
Scatchard Analysis and Immunoblotting 
To verify that the specific binding assays were representative 
of changes in receptor number and not affinity, Scatchard 
analyses were carded out at selected doses and time inter- 
vals. The results (Fig. 2) revealed curvilinear plots that could 
be resolved into a minority ('x,18%)  of high-affinity and a 
majority of low-affinity sites (Table  III).  One caveat con- 
cerned the GE fraction isolated from livers of rats injected 
15 rain previously with 10/zg EGE For these conditions, the 
high concentration of internalized ligand (Table  I) vitiated 
the calculations of receptor content and affinity constants by 
the LIGAND program (28), which was used as the quantity 
Table I1. Correction Factor for Direct Binding of 12SI-EGF to Subcellular Fraction 
Correction factor at various times (min) after EGF injection 
Subcellular  Dose of 
fraction  EGF  0.5  I  2.5  5  15  30  60  !  20 
i~gHO0 g body weight 
PM  0.1  1.21  1.20  1.20  1.20  1.19  1.20  1.06  1.06 
1  1.44  1.41  1.39  1.39  1.35  1.35  1.20  I. 13 
10  1.87  1.82  1.82  1.78  1.78  1.56  1.32  1.26 
GE  0.1  1.19  1.23  1.28  1.33  1.35  1.35  1.23  1.19 
1  1.41  1.43  1.72  1.82  2.00  1.75  1.61  1.19 
10  1.47  1.85  3.70  5.00  4.17  3.23  2.13  1.72 
TP  0.1  1.06  1.06  1.05  1.01  1.03  1.00  1.01  1.01 
l  1.14  1.13  1.13  1.13  1.13  1.10  1.06  1.03 
10  1.28  1.28  1.32  1.40  1.44  1.36  1.32  1.16 
Correction factors were calculated as the ratio of ~SI-EGF bound to control (uninjected)  PM fractions (mean of 10 preparations) in the absence of cold EGF and 
~zSI-EGF bound in the presence of that EGF content determined from Table I as described in Materials and Methods. 
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Figure 2.  Scatchard analysis 
of  125I-EGF binding  to  (.4) 
PM,  (B)  GE,  and  (C)  TP 
fractions.  PM,  GE,  and  TP 
fractions were prepared from 
control  (uninjected) (o)  and 
at 15 (&) and 120 min (e) af- 
ter the injection of 1/zg EGF/ 
100 g body weight. 
of endogenous internalized EGF even by 2.5 min after EGF 
injection was saturating. Consequently, immunoblotting was 
carded out with a site-specific antibody to the cytosolic do- 
main of the  EGF receptor as described in Materials and 
Methods.  A  time-dependent decrease in  receptor content 
was observed for PM, with a marked progressive increase 
in receptor content observed in GE fractions isolated from 
liver homogenates at 0-15 rain after ligand injection. Quanti- 
tation by densitometry (Fig. 3, bottom) confirmed the tem- 
poral differences in receptor content for the two fractions. 
Dose of EGF  Injected and In Viva Receptor Occupancy 
An in viva inhibition dose-response study was carried out 
for PM and GE fractions isolated at 15 min after the injection 
of tracer doses of ~25I-EGF and increasing doses of unla- 
beled EGF (Fig. 4). The extent of receptor occupancy was 
calculated by converting the data to femtomoles EGF bound 
or internalized per milligram cell fraction protein. At doses 
of 5-10  /zg  EGF  injected,  maximal  surface  receptor oc- 
cupancy  was  observed.  From  the  in  viva  displacement 
curves at 0.1, 1, and 10/~g EGF injected, estimates of recep- 
tor occupancy were 7%, 50%, and saturation, respectively. 
Receptor Recycling and Downregulation 
The observations of Figs.  1 and 2 were pursued in greater 
detail. Notably, the unexpected return by 120 min to basal 
(zero time) levels of receptor content in PM fractions after 
the injection of 0.1, 0.5, and 1/~g of EGF/100 g body weight 
was considered as a possible receptor recycling event. The 
lack of receptor return at the 5- and 10-/zg doses was consid- 
ered as a possible reflection of ligand-mediated downregu- 
lation. 
Replicate studies were carried out on control (uninjected) 
rats and also at 15 and 120 rain after the injection of 0.1,  1, 
and 10/zg EGF (Fig. 5) confirming the observations of Figs. 
1 and 2.  To assess  the contribution of newly synthesized 
receptor to the dose-regulated return of receptor in PM at 
120 min,  identical experiments were carried out in cyclo- 
heximide-treated rats  (Fig.  5)  in  which  protein  synthesis 
was inhibited by >95 %.  Although receptor loss was more 
marked at 15 min after ligand injection, receptor content in 
the PM fraction returned to near initial levels for the 0.1-/~g 
dose of injected EGF and to 80% of initial levels at the 1-#g 
dose. At the 10-/zg dose, the receptor content of PM at 120 
min was identical to that at 15 min after ligand injection. 
Although the return by 120 rain to basal receptor levels in 
cycloheximide-treated rats was consistent with recycling, an 
alternative hypothesis has been proposed by Dunn et al. (15) 
Table IlL Scatchard Analysis of 1251-EGF  Binding to Subcellular Fractions 
Time 
Subcellular  after EGF 
fraction  EGF injected  injection 
Binding parameters 
K,  N,  K2  N2 
/~g/lO0 g  body weight  rain  x  lO  9 M -I  final~rag  x  lO  s M -I  final~rag 
PM  0  0  8.2  512  2.8  2,125 
1  15  7.8  121  2.1  875 
1  120  7.2  502  2.4  2,050 
GE  0  0  7.4  162  4.1  927 
1  15  15.1  614  3.7  2,702 
1  120  7.2  176  4.3  989 
TP  0  0  8.1  38  2.9  146 
I  15  8.1  32  3.3  138 
1  120  7.2  34  2.7  140 
Binding parameters were determined from Scatchard analyses that were fitted on the basis of a two-site model (28) to obtain receptor number (N~, high affinity 
receptor; N2, low affinity receptor) and affinity constants (Kh high affinity constant; K2, low affinity constant). Binding was carded out at 4°C for 14 h as de- 
scribed in Materials and Methods. In the TP fractions, binding was carried out in the presence of octylglucoside. 
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injection  (rain) 
Densitometry  1.08  0.42  0.27  0.25  0.15  0.29  0.71  2.27 
(arbitrary  units) 
Figure 3. Immunoblotting of the EGF receptor in 
PM and GE fractions isolated from control (unin- 
jected) rats and at 0.5, 5, and 15 rain after the injec- 
tion of 10 #g EGF/100 g body weight. Immuno- 
blotting was carried out on 50 #g of cell fraction 
protein  of the PM (lanes 1-4) and GE fractions 
(lanes 5-8) as described in Materials and Methods. 
At the bottom of each lane is indicated the amount 
of EGF receptor as determined by densitometry in 
arbitrary  units. 
>, 
•  ~  I00 
8o 
60 
E 
•  ~  20 
o  I00 
N  8o 
.1o 
4O 
LL 
(.9 
IJJ  20 
I 
I--I 
I~1  0  --  .  i 
oJ  ix I0  2 I0  -i 
Doses  EGF 
~0 
!  ! 
I 
io  °  lo'  Io' 
injected (pg/lOOg  bw) 
Figure 4. In viva inhibition dose response of t25I-EGF binding to 
PM and GE fractions. Livers were rapidly excised 15 min after the 
injection of 22  x  106 dpm t25I-EGF (210/zCi//~g sp act) that was 
coinjected  with  increasing  amounts  of unlabeled  EGF (0.05-100 
/zg/100 g body weight).  PM (A) and GE fractions  (B) were pre- 
pared, and the amount of radiolabeled EGF bound to the fractions 
was determined by gamma couming. Calculation of femtomoles of 
hormone bound  showed that  saturation  was achieved at 5-10/zg 
EGF injected. 
in which a large pool of low affinity intracellular receptors 
were suggested to replenish the surface EGF receptor con- 
tent after ligand-mediated internalization.  Accordingly, we 
attempted to evaluate the existence of such a  pool. 
TP fractions were isolated from livers of male rats at vari- 
ous times after the injection of increasing doses of EGF (Fig. 
6).  When direct binding studies were carried out, the data, 
after correction for the endogenous content of EGF, showed 
a rapid (t,~ <  1 min) loss of binding sites at the 1- and 10-~g 
doses. The extent of receptor loss was maximal at 15 min and 
was dose dependent. That this loss was due to entry of recep- 
tor into a cryptic compartment was demonstrated when the 
binding studies were carried out on fractions treated with the 
detergent octylglucoside (Fig. 6, solid symbols) or on the TP 
fraction frozen and thawed three times (not shown).  Under 
these conditions,  no loss of binding  sites was observed at 
doses of 0.1 or 1/~g EGF injected.  Only at the 10-/zg dose 
was a  slower exponential loss of binding sites obsetwed (t,~ 
•2h). 
Scatchard analysis of EGF binding to the TP fraction (Fig. 
2  C) showed identical curvilinear Scatchard plots to those 
observed for PM and GE fractions. By the two-site model, 
similar affinities of the  high  and  low affinity receptors to 
those in PM and GE fractions were found (Table III). Only 
the receptor concentration was lower than that for the PM 
and GE fractions. The Scatchard analyses on TP fractions 
also permitted an estimate of receptor yields in the PM and 
GE fractions (Table IV). 
The suggestion (15) of a pool of cryptic low affinity recep- 
tors of Kd ,,o 200 nM  was not supported by the  studies of 
Fig. 2. Direct binding studies (Figs. 1 and 6) were consistent 
with the immunoblot data carded out at the 10-/zg dose (Fig. 
3) and were considered reflective of receptor content. Conse- 
quently,  the effect of injected  EGF on receptor content of 
liver parenchyma was assessed by direct binding  (Fig.  7). 
Only at 5- and 10-1zg doses of injected EGF was net receptor 
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Figure  5.  Reappearance by  120 
min of initial EGF receptor con- 
tent of PM at low (0.1 and 1 #g) 
but not high (10/~g) doses of EGF 
injected.  Specific  binding  was 
carried out on PM fractions iso- 
lated at 0 (without EGF injection), 
15, and 120 rain from rats injected 
with 0.1  (O),  1 (A), and  10 /xg 
EGF (e) from control  (without 
cycloheximide)  (-CHX) or cyclo- 
heximide-treated  rats and corrected 
for the endogenous  content  of EGF 
as  described  in  Materials  and 
Methods. Parentheses refer to the 
number of experiments for each 
time point (mean +  SD for n >t 
3 or mean + half of the variation 
for n = 2). All binding assays for 
each experiment were carried out 
in triplicate. Slightly lower receptor levels were observed in PM fractions isolated at 15 and 120 min after ligand injection into cyclo- 
heximide-treated rats as compared with control rats. The difference presumably represents the pool of newly synthesized receptors. 
loss (i.e., downregulation) observed at 120 rain after ligand 
injection. Immunoblotting on TP fractions was not possible 
due to the lack of sensitivity of the procedure in the crude 
fraction. 
Ligand  Clearance 
The binding studies carried out on the TP fractions (Fig. 6) 
and PM and GE fractions (Fig. 1) were consistent. Taken to- 
gether, the observations indicated that receptor was internal- 
ized in a ligand-mediated fashion. At low subsaturating doses 
of injected ligand (<1 tzg), receptors returned to initial levels 
on the cell surface but were lost at higher ligand doses. The 
contribution of ligand availability in vivo to recycling and 
downregulation was next addressed.  '25I-EGF was injected 
into the portal vein at doses of 0.1,  1, and 10/zg/100 g body 
weight, and the content of "ICA-precipitable radiolabel was 
evaluated in plasma samples and liver homogenates (Fig. 8). 
Rapid loss from the circulation (Fig. 8) of TCA-precipitable 
~25I-EGF was  found for all  doses of EGF injected.  Curi- 
ously, between 30 and 60 rain after injection, TCA-precip- 
itable 12q-EGF reappeared in the circulation after the 0.1- 
and 1-#g doses of injected EGF (Fig. 8, arrows)  but not the 
10-#g dose.  The clearance of ligand from liver was more 
prolonged than from plasma but with similar overall rates 
observed for the different doses of injected EGF such that by 
90 min after injection, 78, 85, and 80% of maximal levels 
of radiolabel were lost from liver after the injection of 0.1, 
1, and 10 #g EGF, respectively. 
Discussion 
These studies  have defined the  in  vivo dose  response of 
receptor internalization,  recycling, and downregulation of 
the EGF receptor in liver parenchyma. The binding of la- 
beled EGF to receptors in defined subcellular fractions iso- 
lated from liver homogenates was considered an accurate 
reflection of changes in receptor content occurring at the cell 
surface and in endosomes. We have previously used identical 
protocols for separating PM from GE fractions to study EGF 
receptor kinase activity therein (19).  Based on SDS-PAGE 
and electron microscopy of random views of the fractions, 
we confirmed that the fractions were not cross-contaminated 
(data not shown). Hubbard et al. (17) have characterized the 
PM fraction extensively. The GE fraction consists of a mix- 
ture of Golgi apparatus and endosomes. The fraction has 
been previously characterized enzymatically and morpho- 
logically (3, 4, 33) as well as by electron microscopic radio- 
autography for the components containing internalized nsI- 
EGF (5,  19). 
That the direct binding studies reasonably reflected recep- 
tor content was a consideration of the Scatchard analyses of 
Fig. 2 and the immunoblot data of Fig. 3. No difference in 
the affinity constants of the EGF receptor was noted in PM 
and GE fractions. An identical conclusion was made by Des- 
buquois et al. (13) and Khan et al. (21) who studied the insu- 
lin receptor in PM and GE fractions by similar methods. 
Hence, the direct binding studies carried out at 10  -I° M 'zsI- 
EGF were not vitiated by changes in affinity that might have 
occurred to the receptor during internalization. The immu- 
noblots were carried out at a saturating dose (10 #g EGF) of 
injected ligand. These studies showed that the receptor con- 
tent changed in PM and GE fractions similar to that observed 
by direct binding. Hence, direct binding after consideration 
and correction for the content of endogenous ligand was a 
valid estimate of the relative receptor content in the PM and 
GE fractions. 
The EGF receptor is considered to be an example of a 
receptor that is degraded shortly after ligand-mediated inter- 
nalization (14,  15,  22,  23,  27,  35).  It was therefore unex- 
pected that after internalization, the receptor content in PM 
fractions returned to starting levels and that the extent of this 
return was  related approximately inversely to the dose of 
ligand injected. Experiments carried out on cycloheximide- 
treated rats  ruled out the possibility that the majority of 
receptors returning to the cell surface were newly synthe- 
sized. Receptor recycling was therefore considered as an ex- 
The Journal of Cell Biology, Volume 109,  1989  2746 1  2  Iff  Table IV.  Yield and Receptor Content of Subcellular 
e-  I"  -,  A,O. I ~Jg  Fractions Isolated  from Liver Homogenates of Control  i  (Uninjected)Rats 
Subcellular  Protein yield 
O  8  fraction  of fraction*  Receptor contentt 
mg/g liver (n)  No./g liver X lO-tl 
TP  123.7 +  1.9 (44)  137 
4  PM  1.19 + 0.2 (32)  19  ID  GE  0.59 -I- 0.2 (42)  4 
~..  * No  difference  was found in the  isolated from  significant  yield of fractions 
the values  0  I  !  !  !  uninjected or EGF-injected  rats. Consequently,  represent  the mean 
•  ~  of all experiments :1: SD. The number of separate experiments  is indicated  in 
parentheses. 
12  '~  B I I.O ~Jg  iow~;  Recept°rand  highC°ntentaffinityWaSreceptors.Calculated  from Table  III and represents  the sum of 
8  ",  . .~  lar low affinity EGF receptors that would replenish surface- 
t  ....  -  located EGF receptors after internalization.  According to 
o 
,,..  ~--~  ....  ~ °"  this model, receptor recycling is not necessary to account for 
their findings. Our attempts to identify, by direct binding, the 
¢~9  "  existence of such a pool were without success. TP fractions  4 
revealed receptors of the same affinities as PM and GE frac- 
tions even after treatment with detergent to expose any latent 
0  I  i  i  ,  binding sites. (Latency for binding was observed in TP frac- 
tions but not GE fractions after 14 h of incubation in hypo-  -cg 12  tonic buffer. This may be related to the ditference in protein 
concentration of  the respective fractions in the binding assay; 
g:  protein concentrations of TP and GE fractions were 2 and 
:~  0.1  mg/ml,  respectively. Electron microscopy showed that 
"~  8  ];  |~~  GE fractions after 14 h of incubation were disrupted, per- 
miring access of the '25I-EGF to intraluminal binding sites 
O  within endosomes.) Furthermore, quantitative immunoblot- 
....  .......... *i  ('}Ira  m  i  .  :3 
-  o  40  8o  12o  ,,  -- 
Time  (min)  after  EGF  injection  ®  'j 
Figure 6.  125I-EGF specific binding to TP fractions  at  various  ~  es  J--  _  ,..,. 
times after the injection of (A) 0.1, (B) 1, and (C) 10 #g EGF/100  tt. 
g body weight. Rats were killed at the indicated times after the in-  uaO" ~  8  ~~  | 
jections of EGF, the TP fraction was isolated from liver homogen-  i  0  i 
/ 
ates, and specific binding was carried out with 10  -t° M ~2SI-EGF 
in the presence (o) or absence (0) of 0.05% octylglucoside. Spe- 
cific binding was evaluated and corrected for the presence of  endog- 
enous EGF as described in Materials and Methods and Tables I and 
II and expressed as femtomoles EGF specifically bound per milli- 
gram cell fraction protein. Results are the mean of three separate 
experiments -t- SD. 
ca.  -  b  I 
planation  of the  results.  (Murthy  et  al.  [29]  have  also 
reported the recycling of EGF receptors in murine 3T3 and 
human WI-38 cells; however, observations based on direct 
binding were not evaluated for the contribution of newly syn- 
thesized EGF receptor.) 
To account for the continued endocytosis of EGF in per- 
fused livers treated with cycloheximide, Duma  et al.  (15) 
postulated the existence of a large pool of crYptic intracellu- 
¢n  Log  EGF  injected 
(pg /  IOOg bw ] 
Figure 7. Specific binding of l0  -I° M 125I-EGF in the presence of 
octylglucoside (0.05%) to rat liver TP fractions isolated at 120 rain 
after the injection of 0.1, 0.5,  1, 5, and  10 #g EGF/100 g body 
weight. Data were from three separate experiments for each dose 
of EGF injected (mean +  SD). 
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Figure 8.  Clearance of injected EGF from the circulation (/eft) or 
liver parenchyma (right).  0.1, 1, and 10/~g '25EGF (180/xCi//~g sp 
act)/100 g body weight was injected into the hepatic portal vein. At 
various times  thereafter,  plasma  was  collected from the  aorta. 
Plasma samples and liver homogenates were precipitated with ice- 
cold 10% TCA for 30 min, and TCA-precipitable  radioactivity was 
determined. The arrows point to increases in "I£~A-precipitable  ra- 
diolabel in plasma occurring between 30 and 60 min after injection. 
Despite the different doses of EGF administered, the kinetics of 
clearance for each dose from the circulation or liver parenchyma 
are remarkably similar. 
ting with the site-specific antibody to the cytosolic domain 
of the EGF receptor failed to detect a high concentration of 
receptors in the GE fraction isolated from control (unin- 
jected) rats (Fig. 3, lane 5). The GE fraction was recovered 
at a buoyant density of 1.09 g/c  3 on sucrose gradients-i.e., 
within the density range (1.08-1.12  g/cm  3) of the compart- 
ment reported (15) to harbor the low affinity EGF receptors. 
We therefore could not confirm the presence of an extensive 
cryptic pool of low affinity receptors and conclude that previ- 
ously internalized receptor recycled to the cell surface when 
surface receptor occupancy was <50%. Also noteworthy was 
the finding that a proportion of internalized ligand also reap- 
peared in the circulation between 30 and 60 min after the in- 
jection of 0.1 and 1/~g EGF but not 10/~g EGF (Fig. 8, ar- 
rows), suggesting that a portion.of the reappearing receptors 
were ferrying previously internalized ligand and/or partially 
processed ligand (24, 31,  38). 
From the receptor content and yield of TP fractions (Table 
IV) the number of EGF receptors per hepatocyte may be cal- 
culated. Weibel et al. (37) have estimated 1.58  x  108 hepa- 
tocytes for 1 g liver. Since all membrane-bound EGF recep- 
tors  would  be  represented  in  the  TP  fraction  we  then 
calculate  87  x  103  EGF  receptors per  hepatocyte.  This 
number is less than that originally calculated by Dunn et al. 
(14)  from Scatchard analyses of '2SI-EGF binding to liver 
homogenates. The yield of receptors recovered in PM and 
GE fractions could also be estimated from Table HI, with 
13.9% of total receptors recovered in PM fractions and 2.9% 
in GE fractions isolated from control (uninjected) rats, and 
indicates the limitations (low yield) of the preparative sub- 
cellular fractionation protocols. 
The studies with the TP fraction also defined the dose re- 
sponse of  downregulation in liver parenchyma. After saturat- 
ing doses of injected ligand, net receptor loss was observed 
in TP fractions concomitant with a lack of receptor replen- 
ishment in PM fractions. These studies do not rule out recy- 
cling in downregulation as only net changes in receptor pools 
and not the flux of individual receptors was measured in our 
studies. Nevertheless, the changes in receptor content of the 
PM were ligand mediated. The molecular signals for recep- 
tor internalization are as yet poorly defined although ligand- 
mediated receptor oligomerization and trapping of EGF and 
low density lipoprotein receptor cytosolic domains by adap- 
tins in clathrin-coated pits have been proposed as has recep- 
tor phosphorylation (7, 30). After internalization, however, 
our studies indicate that a choice is made, presumably within 
the endosome. Either the receptors return to maintain the ini- 
tial surface receptor level or they are transported to a degra- 
dative compartment, presumably the lysosome. The choice 
must be some consequence of the concentration of internal- 
ized ligand and receptor but not the time with which ligand 
remains available to receptor as clearance was similar from 
the circulation or liver parenchyma for all doses of injected 
EGE 
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